Intranasal vaccine shows broad SARS-CoV-2 variant protection
Coronavirus
By Tarun Sai Lomte Reviewed by Benedette Cuffari, M.Sc. Sep 1 2024 Harnessing the power of a single dose, this innovative vaccine offers a potent defense against both current and future COVID-19 threats. Study: A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants. Image Credit: Phonlamai Photo / Shutterstock.com A recent study published in Nature Communications determined the efficacy of a codon-deoptimized intranasal
din zilele anterioare